PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-19646 IBM CVE debrief

IBM Common Licensing Agent and ART products are vulnerable to a redirect vulnerability due to improper validation of the HTTP Host header, potentially allowing a remote attacker to redirect users to an arbitrary domain. This issue affects multiple product versions and requires verification and patching to prevent potential exploitation. Affected systems, particularly those exposed to the internet or used by multiple users, need to be assessed for vulnerability and prioritized for patching.

Vendor
IBM
Product
Common Licensing
CVSS
CRITICAL 9.1
CISA KEV
Not listed in stored evidence
Original CVE published
2026-09-10
Original CVE updated
2026-09-11
Advisory published
2026-09-10
Advisory updated
2026-09-11

Who should care

Defenders responsible for IBM Common Licensing Agent and ART products, particularly those exposed to the internet or used by multiple users, should assess their systems for potential vulnerability and prioritize patching.

Why it matters

Defenders should care about CVE-2026-19646 because it allows a remote attacker to redirect users to an arbitrary domain, potentially leading to phishing attacks, unauthorized access, or disruption of service. Affected systems, particularly those exposed to the internet or used by multiple users, require verification and patching to prevent potential exploitation.

  • Potential for phishing attacks through redirects
  • Risk of unauthorized access to sensitive information
  • Possible disruption of service or user experience
  • Need for verification of affected systems and patching

Technical summary

The vulnerability exists in IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 due to improper validation of the HTTP Host header. This allows a remote attacker to redirect users to an arbitrary domain, potentially leading to phishing attacks or unauthorized access. Defenders should prioritize verifying and patching affected systems, particularly those exposed to the internet or used by multiple users, to prevent potential exploitation.

Defensive priority

Defenders should prioritize verifying and patching affected systems, particularly those exposed to the internet or used by multiple users.

Recommended defensive actions

  • Verify and apply patches for affected IBM Common Licensing Agent and ART products
  • Restrict access to affected systems to trusted users only
  • Monitor for suspicious activity or potential redirects

Evidence notes

The CVE record and NVD entry provide limited information about the vulnerability. Further verification is required to determine the full scope of affected systems and potential impact.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-19646 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-19646

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-19646 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-19646

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.